Article
The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer’s Disease
24 Jan 2022
Abstract excerpt
Amyloid-beta (Aβ) deposition in the brain is closely linked with the development of Alzheimer’s disease (AD). Unfortunately, therapies specifically targeting Aβ deposition have failed to reach their primary clinical endpoints, emphasizing the need to broaden the search strategy for alternative targets/mechanisms. Transglutaminase-2 (TG2) catalyzes post-translational modifications, is present in AD lesions and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
